BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korotkova TM, Eriksson KS, Haas HL, Brown RE. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 2002;104:83-9. [PMID: 11830281 DOI: 10.1016/s0167-0115(01)00323-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Winsky-Sommerer R, Boutrel B, de Lecea L. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol 2005;32:285-94. [PMID: 16385142 DOI: 10.1385/MN:32:3:285] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
2 Sharma R, Sahota P, Thakkar MM. Role of adenosine and the orexinergic perifornical hypothalamus in sleep-promoting effects of ethanol. Sleep 2014;37:525-33. [PMID: 24587575 DOI: 10.5665/sleep.3490] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
3 Takakusaki K, Takahashi K, Saitoh K, Harada H, Okumura T, Kayama Y, Koyama Y. Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol 2005;568:1003-20. [PMID: 16123113 DOI: 10.1113/jphysiol.2005.085829] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 4.4] [Reference Citation Analysis]
4 Teske JA, Billington CJ, Kotz CM. Mechanisms underlying obesity resistance associated with high spontaneous physical activity. Neuroscience 2014;256:91-100. [PMID: 24161277 DOI: 10.1016/j.neuroscience.2013.10.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
5 Yu L, Zhang XY, Chen ZP, Zhuang QX, Zhu JN, Wang JJ. Orexin excites rat inferior vestibular nuclear neurons via co-activation of OX1 and OX 2 receptors. J Neural Transm (Vienna) 2015;122:747-55. [PMID: 25371350 DOI: 10.1007/s00702-014-1330-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
6 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
7 Brown RE, McKenna JT, Winston S, Basheer R, Yanagawa Y, Thakkar MM, McCarley RW. Characterization of GABAergic neurons in rapid-eye-movement sleep controlling regions of the brainstem reticular formation in GAD67-green fluorescent protein knock-in mice. Eur J Neurosci 2008;27:352-63. [PMID: 18215233 DOI: 10.1111/j.1460-9568.2008.06024.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
8 Li Y, van den Pol AN. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 2005;25:173-83. [PMID: 15634779 DOI: 10.1523/JNEUROSCI.4015-04.2005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
9 Srinivasan S, Simms JA, Nielsen CK, Lieske SP, Bito-Onon JJ, Yi H, Hopf FW, Bonci A, Bartlett SE. The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration. PLoS One 2012;7:e44726. [PMID: 23028593 DOI: 10.1371/journal.pone.0044726] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
10 Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003;23:7-11. [PMID: 12514194 [PMID: 12514194 DOI: 10.1523/jneurosci.23-01-00007.2003] [Cited by in Crossref: 369] [Article Influence: 19.4] [Reference Citation Analysis]
11 Vittoz NM, Schmeichel B, Berridge CW. Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. Eur J Neurosci 2008;28:1629-40. [PMID: 18973582 DOI: 10.1111/j.1460-9568.2008.06453.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
12 Korotkova TM, Ponomarenko AA, Brown RE, Haas HL. Functional diversity of ventral midbrain dopamine and GABAergic neurons. Mol Neurobiol 2004;29:243-59. [PMID: 15181237 DOI: 10.1385/MN:29:3:243] [Cited by in Crossref: 54] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
13 Boutrel B, de Lecea L. Addiction and arousal: the hypocretin connection. Physiol Behav. 2008;93:947-951. [PMID: 18262574 DOI: 10.1016/j.physbeh.2007.11.022] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
14 Liu MF, Xue Y, Liu C, Liu YH, Diao HL, Wang Y, Pan YP, Chen L. Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson's Disease. Front Neurosci 2018;12:835. [PMID: 30524223 DOI: 10.3389/fnins.2018.00835] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
15 Schöne C, Burdakov D. Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain. Curr Top Behav Neurosci 2017;33:51-74. [PMID: 27830577 DOI: 10.1007/7854_2016_45] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
16 Kim SJ, Lyoo IK, Lee YS, Sung YH, Kim HJ, Kim JH, Kim KH, Jeong DU. Increased GABA levels in medial prefrontal cortex of young adults with narcolepsy. Sleep 2008;31:342-7. [PMID: 18363310 DOI: 10.1093/sleep/31.3.342] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
17 Kukkonen JP, Leonard CS. Orexin/hypocretin receptor signalling cascades. Br J Pharmacol 2014;171:314-31. [PMID: 23902572 DOI: 10.1111/bph.12324] [Cited by in Crossref: 104] [Cited by in F6Publishing: 91] [Article Influence: 13.0] [Reference Citation Analysis]
18 Liu MF, Xue Y, Liu C, Liu YH, Diao HL, Wang Y, Pan YP, Chen L. Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson's Disease. Front Neurosci 2018;12:835. [PMID: 30524223 DOI: 10.3389/fnins.2018.00835] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Gao HR, Zhuang QX, Zhang YX, Chen ZP, Li B, Zhang XY, Zhong YT, Wang JJ, Zhu JN. Orexin Directly Enhances the Excitability of Globus Pallidus Internus Neurons in Rat by Co-activating OX1 and OX2 Receptors. Neurosci Bull 2017;33:365-72. [PMID: 28389870 DOI: 10.1007/s12264-017-0127-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
20 Carletti F, Ferraro G, Rizzo V, D'Agostino S, Lonobile G, Sardo P. Nitric oxide- and cGMP-active compounds affect the discharge of substantia nigra pars reticulata neurons: in vivo evidences in the rat. J Neural Transm (Vienna) 2009;116:539-49. [PMID: 19350217 DOI: 10.1007/s00702-009-0216-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
21 Chen L, Brown RE, McKenna JT, McCarley RW. Animal models of narcolepsy. CNS Neurol Disord Drug Targets 2009;8:296-308. [PMID: 19689311 DOI: 10.2174/187152709788921717] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
22 Brown RE, Sergeeva OA, Eriksson KS, Haas HL. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 2002;22:8850-9. [PMID: 12388591 [PMID: 12388591 DOI: 10.1523/jneurosci.22-20-08850.2002] [Cited by in Crossref: 228] [Article Influence: 11.4] [Reference Citation Analysis]
23 Hrabovszky E, Molnár CS, Borsay BÁ, Gergely P, Herczeg L, Liposits Z. Orexinergic input to dopaminergic neurons of the human ventral tegmental area. PLoS One 2013;8:e83029. [PMID: 24376626 DOI: 10.1371/journal.pone.0083029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
24 Zhang XY, Yu L, Zhuang QX, Zhu JN, Wang JJ. Central functions of the orexinergic system. Neurosci Bull 2013;29:355-65. [PMID: 23299718 DOI: 10.1007/s12264-012-1297-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
25 Leonard CS, Kukkonen JP. Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol 2014;171:294-313. [PMID: 23848055 DOI: 10.1111/bph.12296] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
26 Yamanaka A, Tabuchi S, Tsunematsu T, Fukazawa Y, Tominaga M. Orexin directly excites orexin neurons through orexin 2 receptor. J Neurosci. 2010;30:12642-12652. [PMID: 20861370 DOI: 10.1523/jneurosci.2120-10.2010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
27 Bernstein DL, Badve PS, Barson JR, Bass CE, España RA. Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine. Addict Biol 2018;23:1032-45. [PMID: 28971565 DOI: 10.1111/adb.12553] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]